Conflicts of Interest
ALR, EMN, TG, and LS have no conflicts of interest to declare. TM is a
board member of the International Papillomavirus Society. LLV reports
grants from Merck & Co. and personal fees from Merck & Co. outside the
submitted work. ELF reports grants to his institution from CIHR and the
National Institutes of Health during the conduct of the study; and
personal fees from Merck. MZ and ELF hold a patent related to the
discovery “DNA methylation markers for early detection of cervical
cancer”, registered at the Office of Innovation and Partnerships,
McGill University, Montreal, Quebec, Canada.